ABSTRACT
We report a case of acute icteric hepatitis attributed to goserelin acetate, occurred during prostate cancer treatment. Gosereline acetate could induce acute hepatitis, which characteristics are close to autoimmune hepatitis type I and may require hepatic monitoring.
Subject(s)
Antineoplastic Agents, Hormonal/adverse effects , Autoimmune Diseases/chemically induced , Chemical and Drug Induced Liver Injury/etiology , Chemical and Drug Induced Liver Injury/immunology , Goserelin/adverse effects , Humans , Male , Middle AgedABSTRACT
Over the last 40 years, the dynamics of hepatitis C virus (HCV) infection in drug users has been affected by the illicit drug market, the health environment including the devastating impact of the HIV/AIDS epidemic which erupted in the 1980s, and the diffusion of substitution treatment beginning in 1995. The purpose of this literature review is to present the dynamics of HCV infection in drug users in France over the last 40 years. Two prevalence studies of HCV infection in the general population were conducted by the French Institute for Public Health Surveillance in 1994 and 2004 and were the touchstone data sources for this analysis. Hypotheses constructed from the findings of these two studies were examined in light of results reported by multicentre prevalence and incidence studies in drug-user populations. The incidence of HCV infection in drug users in France reached a peak in the late 1980s or early 1990s after a lengthy period of epidemic expansion. Implementation of a risk reduction policy enabled a very significant reduction in the incidence of HCV infection in drug users over the last 20 years, leading to incidence figures which are now 10-15% of the 1990 estimate.
Subject(s)
Epidemics , Hepatitis C/epidemiology , Substance Abuse, Intravenous/epidemiology , France/epidemiology , Hepatitis C/diagnosis , Humans , IncidenceABSTRACT
BACKGROUND: In order to evaluate the incidence and risk factors of infection by hepatitis C virus (HCV) among intravenous drug users we conducted a prospective cohort study of HCV and HIV negative IVDU in the North and East of France. METHODS: Two hundred and thirty-one IVDU who had injected drug at least once in their lifetime and were negative for anti-HCV and anti-HIV were followed-up every three months over a 12-month period. Serum anti-HCV and anti-HIV antibodies were tested at inclusion in the study and at the end of the follow-up. Data on injection practices and behaviours were collected at inclusion and at each visit, and a test for anti-HCV antibodies was performed on a saliva sample. When this proved positive, an ELISA test for serum anti-HCV antibodies was carried out. RESULTS: Of the 231 participants included, 165 (71.4%) underwent a final HCV and HIV serum test. The incidence was nil for HIV infection and 9% (95% CI: 4.6-13.4) person-years for HCV infection. Among IVDU who injected at least once during the last 6 months HCV infection incidence was 11% (95% CI: 4.7-17.1) person-years. The multivariate analysis carried out on the inclusion data found female sex alone to be an independent predictive factor of HCV seroconversion. In a Cox proportional hazard multivariate analysis that took into account time-dependent exposures and covariates, we found that syringe and cotton sharing were, after adjusting for other covariates, the only independent predictive factors of HCV seroconversion: hazard ratio: 6.3 [corrected] (95% CI: 1.1-35.4; [corrected] p<0.05) and 16.4 (95% CI: 1.4-190.6; [corrected] p<0.05), respectively. CONCLUSION: The transmission of the HCV virus persists among French IVDU despite an ongoing national harm reduction program. Injecting material and cotton sharing are the two major determinants of transmission in this cohort.
Subject(s)
Hepatitis C/epidemiology , Substance Abuse, Intravenous/complications , Adult , Antibodies, Viral/analysis , Cohort Studies , Enzyme-Linked Immunosorbent Assay , Female , Follow-Up Studies , France/epidemiology , HIV Antibodies/analysis , Hepatitis C/immunology , Hepatitis C Antibodies/analysis , Humans , Incidence , Male , Multivariate Analysis , Prospective Studies , Risk Factors , Saliva/immunology , Socioeconomic Factors , Substance Abuse, Intravenous/epidemiology , Time FactorsABSTRACT
In order to evaluate the incidence and risk factors of infection by hepatitis C virus (HCV) among injecting drug users (IDUs), we conducted a prospective cohort study of HCV- and human immunodeficiency virus (HIV)-negative IDUs in the North and East of France. A total of 231 HCV and HIV IDUs who had injected drugs at least once in their lifetime were followed up every 3 months over a 12-month period. Serum anti-HCV and anti-HIV were tested at inclusion in the study and at the end of the follow-up. Data on injecting practices were collected at inclusion and at each visit. Of the 231 participants included, 165 (71.4%) underwent a final HCV and HIV serum test. The incidence was nil for HIV infection and 9/100 person-years (95% CI 4.6-13.4) for HCV infection. In a multivariable analysis, we found that syringe and cotton sharing were the only independent predictive factors of HCV seroconversion.
Subject(s)
HIV Infections/epidemiology , Hepatitis C/epidemiology , Substance Abuse, Intravenous/epidemiology , Adult , Cohort Studies , Female , France/epidemiology , HIV Infections/etiology , HIV Infections/prevention & control , Hepatitis C/etiology , Hepatitis C/prevention & control , Humans , Incidence , Male , Prospective Studies , Risk Factors , Substance Abuse, Intravenous/complications , Surveys and Questionnaires , Syringes/virologyABSTRACT
The authors report a preliminary series assessing the feasibility of duodenal stenting using a surgical approach. The study included 16 patients with a malignant duodenal outlet obstruction for whom a biliaryobstruction necessitated a laparotomyor following an endoscopic stenting failure. The stent was efficient in 15 patients with a complete relieve of obstruction. These patients could have oral intake at the end of the first postoperative week. No stent obstruction occurred. The duodenal stenting by laparotomy could be a good alternative to palliative gastroenteral anasotomosis.
Subject(s)
Duodenal Neoplasms/complications , Duodenal Obstruction/etiology , Duodenal Obstruction/surgery , Laparotomy/methods , Palliative Care/methods , Prosthesis Implantation/methods , Stents , Duodenoscopy , Feasibility Studies , Female , Follow-Up Studies , Humans , Length of Stay/statistics & numerical data , Male , Treatment OutcomeSubject(s)
Bronchogenic Cyst/diagnosis , Deglutition Disorders/etiology , Fever/etiology , Bronchogenic Cyst/complications , Esophagus , Female , Humans , Middle Aged , NeckABSTRACT
OBJECTIVE: The aim of this study was to assess predictive factors for the progression to liver cirrhosis in hepatitis C. METHODS: One hundred thirty six patients (79 men; 57 women; mean age 39 years) with transfusion or intravenous drug use-associated hepatitis C virus (HCV) infection were studied. Sex, cause of infection, duration of contamination, and genotype were studied as predictive factors of progression to liver cirrhosis. RESULTS: One hundred twenty three patients presented with chronic hepatitis without cirrhosis and 13 had cirrhosis. At the time of liver biopsy, rates of cirrhosis were: 0% before 40 years, 10% between 40 and 60 years, and 47% after 60 years. (p < 0.05). Rates of cirrhosis according to the age at the time of contamination were as follows: 3% before 30 years; 16% between 30 and 50 years; 46% after 50 years even though duration of the disease was comparable in the three groups. In multivariate analysis, two independent factors were associated with liver cirrhosis: age at contamination and duration of infection. CONCLUSION: Duration of infection and especially age at contamination seem better correlated with the probability of cirrhosis than the route of transmission or the genotype 1b. The results of this study suggest that progression to cirrhosis is slower in cases of contamination before 30 years of age than later on. Age at the time of contamination is an important predictive factor of progression to cirrhosis.
Subject(s)
Hepatitis C/complications , Liver Cirrhosis/etiology , Adolescent , Adult , Age Factors , Aged , Female , Hepacivirus , Hepatitis C/virology , Humans , Liver Cirrhosis/virology , Male , Middle AgedABSTRACT
Interferon alpha (IFNalpha), a type I interferon, can be considered as a viral infection marker because this cytokine is induced during many viral infections. However, it is quite difficult to detect IFNalpha in sera. Investigations are interested in various intra-cellular IFNalpha-induced proteins as viral infection markers. However the activity of these enzymes increased not only in response to type I IFNs but also to type II IFN. MxA protein can be detected in the cytoplasm of IFNalpha/beta-treated cells, whereas other cytokines, including IFNgamma, are poor inducers. Using an immunochemiluminescent assay, we studied MxA protein in whole blood of 34 patients with various viral infections. The whole blood was drawn into sterile vacuum tubes containing heparin or EDTA. MxA values were relatively similar in heparin-treated samples and EDTA-treated samples, with differences not exceeding 1 ng/ml. The levels of MxA protein were compared in whole blood obtained by using two different lysis procedures. A correlation was found between the MxA levels obtained by using procedure I and procedure II, but higher amounts of MxA protein were found with procedure II. The second procedure is rapid and more convenient than the other and it is carried out in one step which reduce technical problems. High levels of MxA protein were found in peripheral blood cells of patients with acute viral infections (Rotavirus, Adenovirus, RSV, CMV), but MxA protein was not elevated in bacterial infections. The MxA levels were also studied in peripheral blood of 32 HCV positive patients. MxA protein was not found in most of IFNalpha-untreated patients, even those with high viral load. In contrast, high levels of MxA protein were found in IFNalpha-treated patients. MxA quantitation can be considered as a specific marker of acute viral infections, and could be useful in the management of treatment with IFNalpha.
Subject(s)
GTP-Binding Proteins , Proteins/isolation & purification , Virus Diseases/blood , Hepatitis C/blood , Humans , Myxovirus Resistance ProteinsABSTRACT
BACKGROUND: Topical treatments with steroids or mesalazine are the most effective treatments for idiopathic proctitis. AIM: To compare the efficacy and tolerance of mesalazine suppositories vs. hydrocortisone acetate foam in the treatment of acute proctitis. PATIENTS AND METHODS: 242 patients with active idiopathic proctitis were randomized to receive once daily either one Pentasa suppository (mesalazine 1 g) or 100 mg hydrocortisone (Colofoam) for 14-21 days (until remission). Disease activity and tolerance of the treatments were assessed using a daily questionnaire, by physician assessment, and endoscopy score. RESULTS: Both treatments induced a significant reduction in disease activity. Mesalazine suppositories were significantly more effective than hydrocortisone on rectal blood loss (P = 0.002) and mucus (P = 0.02) parameters, and on the degree of the decrease in endoscopy score (P = 0.02). No significant difference was observed between treatments concerning histology or tolerance. CONCLUSION: Mesalazine suppositories were as well-tolerated as hydrocortisone foam, but were more effective for some parameters of disease activity.
Subject(s)
Aminosalicylic Acids/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Anti-Inflammatory Agents/administration & dosage , Proctitis/drug therapy , Acute Disease , Administration, Topical , Adult , Aminosalicylic Acids/adverse effects , Aminosalicylic Acids/therapeutic use , Anti-Inflammatory Agents/adverse effects , Anti-Inflammatory Agents/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Female , Humans , Hydrocortisone , Male , Mesalamine , Proctoscopy , SuppositoriesABSTRACT
A 22-year-old man developed an axonal sensorimotor polyneuropathy and an episode of pyloroduodenal stenosis at the same time. Rectal biopsy established the diagnosis of Crohn's disease. The etiologic investigations were negative. The neurological and gastrointestinal troubles improved and followed a parallel course. Without vitamin deficiency or metronidazole treatment, peripheral polyneuropathy is a rare event in Crohn's disease. An autoimmune cause is suspected.
Subject(s)
Crohn Disease/complications , Peripheral Nervous System Diseases/etiology , Adult , Crohn Disease/immunology , Crohn Disease/therapy , Humans , Leg/innervation , Male , Peripheral Nervous System Diseases/immunology , Peripheral Nervous System Diseases/therapyABSTRACT
OBJECTIVES: The aim of this retrospective study was to evaluate the feasibility and the morbidity of laparoscopic cholecystectomy for acute cholecystitis in elderly patients. METHODS: Among 891 consecutive patients who underwent cholecystectomy, 151 had acute cholecystitis. Fifty three patients of > or = 70 years of age (group 1) were compared to 98 younger patients (group 2). Analysis was made in "intention to treat" so directly open cholecystectomies during the same period were also included. RESULTS: Elderly patients had a lower success rate of laparoscopic treatment (52.8% versus 70.4%; p < 0.05). This difference was due to higher rate of directly open cholecystectomy in the elderly (17% versus 2%). There was no difference between both groups in conversion rate to laparotomy (30.2% versus 26.5%). Surgical morbidity was 7.5% in group 1 and 4% in group 2 (NS). General complications were more frequent in the elderly (p < 0.05). Five patients in group 1 (9.4%) died of general complications of which 3 were operated on directly by open cholecystectomy. There was no mortality in group 2. CONCLUSION: Acute cholecystitis in the elderly remains a severe disease in which laparoscopic treatment is only possible in about fifty percent.
Subject(s)
Cholecystectomy, Laparoscopic , Cholecystitis/surgery , Acute Disease , Aged , Arrhythmias, Cardiac/complications , Cholangiopancreatography, Endoscopic Retrograde , Cholecystectomy , Cholecystectomy, Laparoscopic/adverse effects , Cholecystitis/pathology , Contraindications , Evaluation Studies as Topic , Feasibility Studies , Gangrene , Humans , Intraoperative Complications , Laparotomy , Middle Aged , Postoperative Complications , Retrospective Studies , Sphincterotomy, Endoscopic , Survival Rate , Treatment OutcomeABSTRACT
Adenocarcinoma of the appendix is rarely encountered and is usually discovered fortuitously at pathology examination of the surgical specimen. Six years after surgery for degenerative villous tumor of the appendix, local and parietal recurrence led to surgery in our patient. We present here the indications for complementary hemicolectomy and management of parietal scars resulting from the initial appendectomy.
Subject(s)
Adenocarcinoma, Mucinous , Appendiceal Neoplasms/complications , Cecal Neoplasms/secondary , Muscle Neoplasms/secondary , Neoplasm Recurrence, Local , Adenocarcinoma, Mucinous/complications , Adenocarcinoma, Mucinous/pathology , Adenocarcinoma, Mucinous/secondary , Adenocarcinoma, Mucinous/surgery , Appendiceal Neoplasms/pathology , Appendiceal Neoplasms/surgery , Cecal Neoplasms/pathology , Cecal Neoplasms/surgery , Cicatrix/pathology , Colectomy/methods , Humans , Male , Middle Aged , Muscle Neoplasms/pathology , Muscle Neoplasms/surgery , Neoplasm Seeding , RecurrenceABSTRACT
Elevated antibody levels against the yeast Saccharomyces cerevisiae have been reported in sera from patients with Crohn's disease and not with ulcerative colitis. The aim of the study was to identify the nature of the epitopes supporting this antibody response. Whole cells from different S. cerevisiae strains were selected in immunofluorescence assay for their ability to differentiate the antibody responses of patients with Crohn's disease and ulcerative colitis. Their cell wall phosphopeptidomannans were then tested as antigen in enzyme-linked immunosorbent assay (ELISA) against sera from 42 patients with Crohn's disease, 20 patients with ulcerative colitis, and 34 healthy controls. Graded chemical degradations were performed on the most reactive strain phosphopeptidomannan. The discriminating epitope was determined through gas-liquid chromatography-mass spectrometry. The greatest discrimination among patients with Crohn's disease, ulcerative colitis, and controls was obtained with Su1, a S. cerevisiae strain used in brewing of beer. ELISA directed against phosphopeptidomannan of this strain was 64% sensitive and 77% specific for discriminating Crohn's disease versus ulcerative colitis and 71% sensitive and 89% specific for Crohn's disease versus controls. Periodate oxidation and selective degradation demonstrated that the most important polysaccharide epitope was shared by both the acid-stable and the alkali-labile domains of the phosphopeptidomannan. The determination of oligomannose sequences of S. cerevisiae Su1 phosphopeptidomannans suggested that a mannotetraose, Man (1 --> 3)Man(1 --> 2)Man(1 --> 2)Man, supported the serological response seen in Crohn's disease. Further identification of the immunogen eliciting this antibody response as a marker of the disease may help to understand its etiology.
Subject(s)
Antibodies, Fungal/biosynthesis , Antibody Specificity , Antigens, Fungal/immunology , Crohn Disease/immunology , Epitopes/immunology , Mannans/immunology , Oligosaccharides/immunology , Phosphopeptides/immunology , Saccharomyces cerevisiae/immunology , Adult , Carbohydrate Sequence , Colitis, Ulcerative/diagnosis , Colitis, Ulcerative/immunology , Crohn Disease/diagnosis , Diagnosis, Differential , Enzyme-Linked Immunosorbent Assay , Female , Fluorescent Antibody Technique, Indirect , Humans , Male , Molecular Sequence DataABSTRACT
Hepatocellular carcinoma is an uncommon complication of primary biliary cirrhosis. Hepatocellular carcinoma occurs generally in the end stage of the disease. We report a case of asymptomatic primary biliary cirrhosis complicated by a hepatocellular carcinoma in a 66 year-old man.
Subject(s)
Carcinoma, Hepatocellular/etiology , Liver Cirrhosis, Biliary/complications , Liver Neoplasms/etiology , Aged , Humans , Liver Cirrhosis, Biliary/physiopathology , Male , Risk Factors , Time FactorsABSTRACT
Colonic lymphoma is a rare complication of ulcerative colitis. We report two cases of B cell colonic lymphoma occurring in two patients who had a left-sided ulcerative colitis for 7 and 24 years respectively. The diagnosis was made during surgery in one case and at colonoscopy in the other. Complete remission was achieved after surgery and chemotherapy with a 8-year and 15-month follow-up respectively.
Subject(s)
Colitis, Ulcerative/complications , Colonic Neoplasms/etiology , Lymphoma, B-Cell/etiology , Lymphoma, Large-Cell, Immunoblastic/therapy , Rectal Neoplasms/secondary , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Barium Sulfate , Colectomy , Colonic Neoplasms/diagnostic imaging , Colonic Neoplasms/pathology , Colonic Neoplasms/therapy , Enema , Female , Gastrointestinal Hemorrhage/complications , Gastrointestinal Hemorrhage/etiology , Humans , Lymphoma, B-Cell/diagnostic imaging , Lymphoma, B-Cell/pathology , Lymphoma, B-Cell/therapy , Lymphoma, Large-Cell, Immunoblastic/pathology , Male , Middle Aged , Radiography , Rectal Neoplasms/pathology , Rectal Neoplasms/therapy , Time FactorsSubject(s)
Foreign Bodies/complications , Pancreatic Ducts/diagnostic imaging , Pancreatitis/etiology , Plants, Edible , Acute Disease , Cholangiopancreatography, Endoscopic Retrograde , Female , Foreign Bodies/diagnostic imaging , Foreign Bodies/surgery , Humans , Middle Aged , Pancreatic Ducts/surgery , Pancreaticoduodenectomy , Pancreatitis/diagnostic imaging , Pancreatitis/surgery , RecurrenceABSTRACT
OBJECTIVES: The aim of this study was to assess the prevalence of infection by HCV, HBV, HDV and HIV and their biological and histopathological patterns in 104 intravenous drug users. METHODS AND RESULTS: Seventy-five patients (72%) had anti-HCV antibodies. Transmission was rapid because 33% of those who had been drug users for 6 months or less had anti-HCV antibodies. The contamination rate was very high because 90% of those who had been drug users for 2 years or less had anti-HCV antibodies. Thirty-four (33%) had an HBV marker, and 6 were HBs Ag carriers. None of the patients had anti-HDV antibodies. Only one patient had anti-HIV antibodies. Twenty-five anti-HCV antibody positive drug users underwent liver biopsy. Seven (28%) had normal ALAT levels and 18 (72%) had permanently or intermittently elevated ALAT levels. The mean histological activity on the Knodell index was 4.1 (range: 1-8). CONCLUSIONS: This study indicates that contamination by HCV is almost inevitable after 2 years of intravenous drug use. The low prevalence of HBV, HDV, and HIV infection might be explained by a low endemic state of these viruses in our area.
Subject(s)
Biomarkers/analysis , Hepatitis B/epidemiology , Hepatitis C/epidemiology , Hepatitis D/epidemiology , Substance-Related Disorders/complications , Adolescent , Adult , Female , Hepatitis B/etiology , Hepatitis C/etiology , Hepatitis D/etiology , Humans , Injections, Intravenous , Male , Prevalence , Prospective StudiesABSTRACT
BACKGROUND: It is unclear why different forms of alpha-chain disease protein appear in intestinal fluid. This was studied in a 23-year-old Mauritanian man in whom alpha-chain disease was diagnosed localized to the duodenum and jejunum, nasopharynx, and bone marrow. METHODS: The duodenal infiltrate was studied by immunohistochemistry. Forms of alpha chain-containing proteins in serum and jejunal fluid were analyzed by ultracentrifugation and radioimmunoassays. RESULTS: The infiltrating cells contained alpha-1 chain but no light chains, and approximately 66% showed variable expression of J chain. Serum contained a large fraction of monomeric alpha-chain disease protein, whereas both monomeric and heavier forms appeared in jejunal fluid. Some of the latter were bound to secretory component, and the fluid contained virtually no free component. CONCLUSIONS: Linkage of polymeric alpha-chain disease protein to secretory component depends on balanced synthesis of alpha chains and J chain in the proliferating B cells, giving rise to polymers with binding site for secretory component expressed as an epithelial receptor. Insufficient receptor-mediated transport capacity (either relative and/or because of intestinal crypt reduction) results in passive external transfer of polymers without bound secretory component along with leakage of serum-derived or locally produced monomeric alpha-chain disease protein, the latter presumably originating from immunocytes with little or no J-chain synthesis.
Subject(s)
Body Fluids/chemistry , Immunoglobulin alpha-Chains/analysis , Immunoproliferative Small Intestinal Disease/metabolism , Jejunum/metabolism , Secretory Component/analysis , Adult , Centrifugation, Density Gradient , Humans , Immunoglobulin alpha-Chains/blood , Immunohistochemistry , Male , UltracentrifugationABSTRACT
Jejunal secretion of albumin, immunoglobulins and secretory component was studied using the segmental perfusion technique with an occluding balloon, in two patients with common variable hypogammaglobulinemia and one patient with selective immunoglobulin A deficiency. Results were compared with those of twenty-two controls previously studied under the same conditions. In all three cases, jejunal secretion rate of immunoglobulin A was nil and secretion rates of albumin and immunoglobulin G were increased as compared to controls. Jejunal secretion rate of immunoglobulin M was increased in the patient with selective immunoglobulin A deficiency, normal in one case of common variable hypogammaglobulinemia and almost nil in the other case. Secretory component was secreted in the jejunal lumen mostly or exclusively under a free form depending on partial or total absence of immunoglobulin A and M. This study allowed to confirm in vivo that secretion of secretory component is independent of the presence of immunoglobulins. Intestinal perfusion might be a useful tool in the investigation of immunological diseases of the intestinal tract.